IGM Biosciences, Inc.
IgM Fc and J-chain mutations that affect IgM serum half-life

Last updated:

Abstract:

This disclosure provides an IgM antibody or IgM-like antibody comprising a variant J-chain and/or variant IgM heavy chain constant regions that can confer increased serum half-life upon the antibody.

Status:
Grant
Type:

Utility

Filling date:

23 Mar 2020

Issue date:

26 Jan 2021